INVST’s Langar Global HealthTech ETF LGHT Stock Holding History

INVST’s Portfolio LGHT Stock Details LGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	71,710 +4,019	+6%	+$38.6K	0.07%	234
2025 Q4	$677K	Buy	67,691 +2,683	+4%	+$27.2K	0.07%	216
2025 Q3	$654K	Buy	65,008 +2,348	+4%	+$24.2K	0.07%	221
2025 Q2	$653K	Buy	62,660 +11,228	+22%	+$111K	0.08%	206
2025 Q1	$504K	Buy	51,432 +34,754	+208%	+$367K	0.07%	217
2024 Q4	$170K	Buy	+16,678	New	+$175K	0.02%	241

Other funds holding LGHT

MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

INVST's LGHT Position: Q1 2026 in Review

INVST increased its Langar Global HealthTech ETF (LGHT) stake by 5.9% in Q1 2026, buying an estimated $38.6K and bringing the position to 71,710 shares worth $624K. The position accounts for 0.07% of the portfolio, ranked #234.

INVST first reported a position in LGHT in Q4 2024 and has held it in 6 quarters since. The position peaked at $677K in Q4 2025. 6 funds tracked by Wall St. Rank hold LGHT as of Q1 2026.

INVST held 71,710 shares of Langar Global HealthTech ETF worth $624K as of Q1 2026.
INVST bought 4,019 Langar Global HealthTech ETF shares in Q1 2026, an estimated $38.6K.
Langar Global HealthTech ETF made up 0.07% of INVST's portfolio in Q1 2026, its #234 holding.
INVST first reported a position in Langar Global HealthTech ETF in Q4 2024 and has held it in 6 quarters since.
INVST's Langar Global HealthTech ETF position peaked at $677K in Q4 2025.
6 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q1 2026.

Based on INVST's 13F filing for Q1 2026, filed 13 May 2026.